Levamisole As an Immunotherapeutic Agent in the Treatment of Cancer
Overview
Overview
Journal
World J Surg
Publisher
Wiley
Specialty
General Surgery
Date
1977 Sep 1
PMID
272084
Citations
1
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Adjuvant therapy in colorectal cancer.
House A J R Soc Med. 1984; 77(6):445-50.
PMID: 6737402 PMC: 1439811. DOI: 10.1177/014107688407700601.
References
1.
Amery W
. Double-blind levamisole trial in resectable lung cancer. Ann N Y Acad Sci. 1976; 277(00):260-8.
DOI: 10.1111/j.1749-6632.1976.tb41704.x.
View
2.
Amery W, Spreafico F, Rojas A, Denissen E, Chirigos M
. Adjuvant treatment with levamisole in cancer: a review of experimental and clinical data. Cancer Treat Rev. 1977; 4(3):167-94.
DOI: 10.1016/s0305-7372(77)80023-6.
View
3.
Thulin H, Thestrup-Pedersen K, Ellegaard J
. In vitro parameters of cell-mediated immune reactions in healthy individuals following immune-stimulation attempts with levamisole. Acta Allergol. 1975; 30(1):9-18.
DOI: 10.1111/j.1398-9995.1974.tb02692.x.
View
4.
Tanaka Y
. Effect of lung irradiation on the incidence of pulmonary metastases and its mechanism. Acta Radiol Ther Phys Biol. 1976; 15(2):142-8.
DOI: 10.3109/02841867609132715.
View
5.
Rojas A, Feierstein J, Mickiewicz E, Glait H, OLIVARI A
. Levamisole in advanced human breast cancer. Lancet. 1976; 1(7953):211-5.
DOI: 10.1016/s0140-6736(76)91337-4.
View